clinical trial · NCT07272629
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Cardiac RepolarizationHealthy VolunteersBalinatunfibMoxifloxacinPlacebo
brief summary
This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.
started
Dec 4, 2025
primary completion
Apr 27, 2026
completion
Apr 27, 2026
last updated
Jan 13, 2026
official title
A Phase 1, Multicenter, Randomized, Double-blind, Double-dummy, Placebo- and Positive-controlled, 4-period Crossover Study to Evaluate the Effect of a Single Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol